ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 604,30
0,18%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Intrexon Corporation (XON)

  7. Intrexon Corporation (XON) Actualités

XON

Intrexon (XON)

Intrexon Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:XON
DateHeureSourceTitreSymboleSociété
26/01/202122h05PR Newswire (US)Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional SharesNASDAQ:XONIntrexon Corporation
06/01/202114h05PR Newswire (US)Precigen to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:XONIntrexon Corporation
09/11/202014h05PR Newswire (US)Precigen Reports Third Quarter 2020 and Year-to-Date Financial ResultsNASDAQ:XONIntrexon Corporation
02/11/202022h05PR Newswire (US)Precigen to Announce Third Quarter 2020 Financial Results on November 9th: Will host Pipeline and Data Update Call in Early D...NASDAQ:XONIntrexon Corporation
04/06/202022h24Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XONIntrexon Corporation
04/06/202022h22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XONIntrexon Corporation
19/05/202022h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XONIntrexon Corporation
11/05/202023h05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XONIntrexon Corporation
29/04/202012h25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XONIntrexon Corporation
02/03/202022h57Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XONIntrexon Corporation
14/02/202020h32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XONIntrexon Corporation
11/02/202023h08Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:XONIntrexon Corporation
06/02/202022h25Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:XONIntrexon Corporation
04/02/202023h00Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XONIntrexon Corporation
03/02/202013h30PR Newswire (US)Precigen Completes Series Of Transactions To Solidify Healthcare FocusNASDAQ:XONIntrexon Corporation
22/01/202012h38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XONIntrexon Corporation
09/01/202013h30PR Newswire (US)Triple-Gene Announces Presentation at Upcoming Biotech Showcase Investor ConferenceNASDAQ:XONIntrexon Corporation
06/01/202013h30PR Newswire (US)Precigen Receives FDA Orphan Drug Designation for PRGN-3006 UltraCAR-T™ in Patients with Acute Myeloid Leukemia (AML)NASDAQ:XONIntrexon Corporation
02/01/202016h33PR Newswire (US)Darling Ingredients Acquires 100% of EnviroFlightNASDAQ:XONIntrexon Corporation
02/01/202013h55PR Newswire (US)Intrexon To Achieve $175M Cash Goal, Appoints Helen Sabzevari, PhD, As New President And CEO And Will Change Name To Precigen...NASDAQ:XONIntrexon Corporation
18/11/201913h30PR Newswire (US)Triple-Gene Presented Preliminary Phase 1 Trial Data of Investigational Multigenic Therapeutic Candidate INXN‑4001 for Trea...NASDAQ:XONIntrexon Corporation
12/11/201913h30PR Newswire (US)Intrexon Reports Third Quarter 2019 Financial ResultsNASDAQ:XONIntrexon Corporation
07/11/201913h30PR Newswire (US)Triple-Gene Announces Completion of Enrollment and Dosing in Phase 1 Trial of INXN‑4001, First Multigenic Investigational T...NASDAQ:XONIntrexon Corporation
04/11/201922h05PR Newswire (US)Intrexon to Announce Third Quarter Financial Results on November 12thNASDAQ:XONIntrexon Corporation
22/10/201901h37Dow Jones NewsOil Search Scales Back Production GuidanceNASDAQ:XONIntrexon Corporation
24/09/201910h00GlobeNewswire Inc.Next Green Wave Achieves Operational Milestones For Intrexon’s Botticelli™ Cannabis Plantlet ProductionNASDAQ:XONIntrexon Corporation
19/08/201913h30PR Newswire (US)ActoBio Therapeutics™ Receives IND Green Light for New Antigen-Specific Immunotherapy Study Aimed at Improving Celiac Patie...NASDAQ:XONIntrexon Corporation
12/08/201912h02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XONIntrexon Corporation
08/08/201923h15PR Newswire (US)Intrexon Reports Second Quarter and First Half 2019 Financial ResultsNASDAQ:XONIntrexon Corporation
05/08/201913h30PR Newswire (US)Precigen Announces First Patient Dosed in Phase 1 Study of PRGN-3005 UltraCAR-T™ in Patients with Advanced, Recurrent Plati...NASDAQ:XONIntrexon Corporation
 Showing the most relevant articles for your search:NASDAQ:XON

Dernières Valeurs Consultées

NYSE
MCD
McDonalds
EU
SGO
Cie de SaintGobain
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
EU
DG
Vinci
NYSE
NKE
Nike
EU
LR
Legrand
EU
ORA
Orange
EU
BNP
BNP Paribas
EU
RI
Pernod Ricard
EU
MC
Lvmh Moet Hennessy Louis...
EU
CAP
Capgemini
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés